AffirmHealth Blog

Image showing that a prescription drug monitoring program communicates both ways with pharmacies, allows health care providers to obtain information. In addition, state insurance programs, healthcare licensure boards, state health departments, and law enforcement can also get information from the program.

PDMP's: A discussion For and Against a State By State Monitoring Program

Sep 18, 2018 10:00:00 AM by Jody Lutz posted in Healthcare, PDMPs, Clinician Perspective, chronic pain, Pain Management, Clinical Tools, State Opioid Prescibing Guidelines, Opioid Prescribing Guidelines, prescriber compliance, opioid prescribing, clinical practice improvement activities, patient risk, opioid legislation, Healthcare Databases, controlled substances, electronic decisions support

Pharmacy Times reports that, "The first PDMP program was enacted by New York State in 1918 and was used to monitor prescriptions for cocaine, codeine, heroin, morphine, and opium. With this program, pharmacists were required to report copies of prescriptions to the health department within 24 hours."

Read More
Weekend Round Up

Weekend Round Up: Healthcare Databases, Chronic Pain Patients Feel Caught in Debate and State Updates for Florida, and Connecticut

Jul 8, 2018 7:57:02 PM by Jody Lutz posted in Healthcare, Opioid Epidemic, Opioid Misuse, chronic pain, Integrated Pain, Opioid Therapy, Opioid Doses, Smarter Pain Management, Guidelines, Clinical Tools, State Opioid Prescibing Guidelines, Opioid Prescribing Guidelines, Chronic Pain Guidelines, prescriber compliance, regulations, compliance, opioid prescribing, opioid prescribing compliance, prescription drug monitoring, weekend round up, Medication Assisted Treatment Protocols, tapering, patient safety, Arizona, opioid legislation, opioid abuse, florida, Healthcare Databases, Connecticut, controlled substances

With opioid prescribing regulations being updated, national policy announcements, state guidelines as well as daily commentary regarding the opioid epidemic flooding news outlets, the AffirmHealth Weekend Round Up looks at the top headlines that caught our team’s eye. From controlled substance protocols to research focusing on pain management, addiction medicine, the ER and more provided to you in an easy to access summary. News you can use. Welcome to the Weekend Round Up.

Read More

Michigan: Controlled Substance Legislation UPDATE

Jun 26, 2018 9:03:00 AM by Jody Lutz posted in PDMPs, Opioid Epidemic, chronic pain, Pain Management, Guidelines, Clinical Tools, prescriber compliance, opioid prescribing compliance, prescribing protocols, Medication Assisted Treatment Protocols, risk assessment, Treatment Agreements, Informed Consent, patient safety, Michigan, opioid legislation

In December of 2017, Michigan’s Lt. Governor Brian Calley signed  a comprehensive 10-bill package to address Michigan’s opioid epidemic, substance abuse and drug diversion problems. The multi-faceted package addresses various education initiatives from school aged children to patient informed consent and also covers acute pain prescriptions, MAPS and a variety of other topics impacting the prescribing of controlled substances in Michigan.

Read More
Weekend Round Up

Weekend Round Up - May 2nd

Mar 18, 2018 4:00:00 PM by Jody Lutz posted in Insider, Healthcare, PDMPs, Opioid Epidemic, Guidelines, Clinical Tools, prescriber compliance, opioid prescribing, opioid prescribing compliance, weekend round up

Happy Spring Break! A few of the news stories that caught our eye at AffirmHealth this past week.  

Read More

AffirmHealth: Beyond Pain Management

Jan 9, 2018 10:45:47 AM by Mario Ramirez, MD posted in Smarter Pain Management, Clinical Tools, Opioid Prescribing Guidelines, Chronic Pain Guidelines

One of the questions we get most frequently when we discuss AffirmHealth is, “who are your customers?”  It’s a fair question and broadly speaking, our customers are two-fold:  clinical providers and the patients they serve.  The second follow on question that occasionally comes up is, “do you want to get rid of all opioids?”  To be clear, our goal is not to eliminate opioids.  In fact, we firmly believe in the viable role that opioids have in pain management.  But we also believe that responsible opioid prescribing must be practiced within the boundaries of a relationship founded on trust between the physician and the patient.  Our products are designed to help develop that relationship so that both providers and patients can manage these prescriptions as safely as possible.  Recognizing that different medical specialties have different regulatory demands, we offer solutions in three practice areas:

Read More
Color logo.jpg

AffirmHealth:  Our Value Proposition and the Practices We Serve

Jan 5, 2018 9:15:00 AM by Mario Ramirez, MD posted in Clinician Perspective, Guidelines, Clinical Tools, Chronic Pain Guidelines

When we first founded AffirmHealth in April 2016, we had one goal:  to make opioid prescribing safer for patients and providers.  We did that by automating state opioid database queries so that they integrated with clinicians’ workflow and improved patient safety, maximized provider efficiency, and fixed a headache for both patients and providers.  In 2018, we are going to be dramatically expanding that offering and I wanted to spend some time explaining our value proposition and how we support practices that use our services.  Our focus is still the same:  we recognize that opioids have a critical role in the management of pain.  But even one overdose is too many.  Our goal is to make sure we help drive that number to zero.

Read More
New Toolkit Supports Providers with Prescribing Guidelines - Naomi Kuznets.png

New Toolkit Supports Providers with Prescribing Guidelines

Jun 6, 2017 10:59:56 AM by Mitch Evans posted in Opioid Therapy, Smarter Pain Management, Guidelines, Clinical Tools

The Accreditation Association for Ambulatory Healthcare, Inc. (AAAHC) has released a new toolkit to combat opioid overdose through improved stewardship programs. The resource is designed to help providers review and assess the volume and length of opioid prescriptions and dosages to mitigate risk of patient overdose and death.

Read More

The information presented on or through this website is made available solely for general information purposes and is not intended to substitute for professional, medical or legal advice. We do not warrant the accuracy, completeness, or usefulness of this information. Any reliance you place on such information is strictly at your own risk. We disclaim all liability and responsibility arising from any reliance placed on such materials.